Congratulations to Lindsay Fitzpatrick who has been elected President of the Canadian Biomaterials Society (CBS). This is a three-year term, with Lindsay serving as president-elect this year.
The Canadian Biomaterials Society is an incorporated, not-for-profit organization dedicated to the development of biomaterials science, technology, and education in Canadian universities, industry, and government. CBS was established in 1973 and has a long-standing dedication to undergraduate and graduate biomaterials education. Together with the United States, Europe, Japan, Australia, China and Korea, CBS is a member of the international community of biomaterials societies as represented by the International Union of Societies of Biomaterials Science and Engineering (IUS-BSE).
“I am truly honoured and excited to have the opportunity to serve in this capacity, following my term as a senior board member,” said Lindsay. “I am eager to work alongside fellow board members to continue to grow and enrich the CBS and all its activities, including supporting our trainees through student awards, mentorship programs and chapter activities, promoting the excellent Canadian biomaterials research being done by our members and fostering relationships with clinicians and industry.”
The Fitzpatrick Lab specializes in biomaterials and regenerative medicine, with a strong emphasis on biomaterial host responses, inflammation and wound healing, and Type 1 diabetes. Their research efforts are focused on two major themes: (1) elucidating signaling pathways that induce an inflammatory respond in responding innate immune cells, and (2) developing in vitro human biomaterial host response models for biomaterials development. They are currently applying these themes to explore mechanisms of host responses to implants and devices used to manage Type 1 diabetes, in particular insulin infusion sets. Lindsay was recently awarded an NSERC Discovery Grant as well as NFRF Exploration in support of her research. Recent publication with PhD Candidate Yuxi Zhang: Therapeutic Insulin Analogue Concentrations at Infusion Sites Enhanced the Pro-Inflammatory Response and Apoptosis in an In Vitro Macrophage-Material Interaction Model.